Modafinil Milpharm

Modafinil, the active ingredient in Modafinil Milpharm, is a eugeroic (wakefulness‑promoting agent) presented as an oral tablet for oral use. It treats excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnea‑related sleepiness, and shift work sleep disorder.

GNH USA supplies Modafinil Milpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Modafinil is a eugeroic that promotes wakefulness in sleep‑related disorders.

- Narcolepsy: reduces excessive daytime sleepiness and improves daytime alertness. - Obstructive sleep apnea‑related excessive daytime sleepiness: alleviates residual sleepiness despite optimal apnea therapy. - Shift work sleep disorder: helps maintain alertness during scheduled work hours.

Modafinil may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild to moderate pain often reported. - Nausea: occasional gastrointestinal upset. - Insomnia: difficulty falling or staying asleep. - Anxiety: feelings of nervousness or tension. - Dry mouth: reduced salivation. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Severe rash or Stevens‑Johnson syndrome: requires immediate medical attention. - Psychotic symptoms: hallucinations or delusional thoughts. - Cardiac arrhythmia: irregular heart rhythm. - Hypertension: significant increase in blood pressure. - Elevated liver enzymes: potential hepatic injury. - Anaphylactic reaction: rapid onset of swelling, breathing difficulty.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors.

- Cardiovascular assessment: check blood pressure and heart rate. - Psychiatric history: review for prior psychosis or severe anxiety. - Liver function: obtain baseline hepatic enzymes. - Concomitant CNS stimulants: avoid combined use without supervision. - Pregnancy and lactation: discuss limited safety data. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Modafinil can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase plasma concentrations. - CYP3A4 inducers (e.g., carbamazepine, phenytoin): may reduce efficacy. - Monoamine oxidase inhibitors: risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may lower hormonal effectiveness. - Antidepressants (SSRIs, SNRIs): may heighten insomnia or anxiety. - Alcohol: can amplify central nervous system effects.